Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05096481
Title PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nationwide Children's Hospital
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.